New England Biolabs (United States)

New England Biolabs (United States)

New England Biolabs produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

76%


Total
Publications

1K


Total Open
Publications

792


Total
Citations

46K


Open Access
Percentage

76%


Total
Publications

1K


Total Open
Publications

792


Total
Citations

46K

Wikipedia

Website

Download

Breakdown

9% 52% 15% 24%

Publisher Open

9%

Both

52%

Other Platform Open

15%

Closed

24%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01020304050607080Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

53%OA Journal

OA Journal 53%

340

Hybrid 29%

184

No Guarantees 18%

114

Other Platform Open

Domain 90%

631

Institution 24%

169

Public 22%

153

Preprint 10%

72

Other Internet 8%

56

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
628
Europe PMC
Domain
550
Semantic Scholar
Public
146
bioRxiv
Preprint
58
DOI
Other Internet
30
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
22
University of Sussex - Sussex Research Online
Institution
19
Figshare
Public
15
Harvard University - Digital Access to Scholarship at Harvard (DASH)
Institution
13
CiteSeer X
Other Internet
12
1 / 13

Data updated 27 September 2022

Share

Share

Share